Industry Supported

This webinar is viewable on demand. Optimizing bioanalytical strategies for complex antibody-based therapeutics. When working with bioanalytical antibodies for challenging targets you want to rely on high-quality, reproducible results. Bio-Rad’s (CA, USA) scientists have developed custom and catalog antibodies against different types of biologics, including complex targets such as bispecifics, antibody-drug conjugates (ADCs) and Fc..

Unlock the potential for faster, more comprehensive leukemia characterization with this webinar from Dana-Farber Cancer Institute expert Salvatore Benfatto. Acute leukemia (AL) is an aggressive form of blood cancer that requires precise molecular classification and urgent treatment. However, standard-of-care diagnostic tests are time- and resource-intensive and do not capture the full spectrum of AL heterogeneity,..

Now available to watch on demand End-to-end contract development and manufacturing services for tailor-made GMP ancillary material for cell therapy manufacturing. High-quality ancillary materials for bioprocessing—meeting both functional and safety standards—are essential for the consistent and successful manufacturing of cell therapies destined for clinical use. Building on decades of experience in biologics manufacturing for research..

This session features professionals from Clinical Operations, Clinical Science, Medical Writing, Medical Affairs, and Clinical Research Monitoring, who will discuss their career paths, provide an overview day-to-day responsibilities and discuss key skills needed for careers in clinical development. Presentations will cover how these functions contribute to drug development, from protocol design and site management to..

Empowering precision medicine: advanced B-cell profiling to guide personalized autoimmune therapies and validate immune reset strategies. Join us for an in-depth webinar exploring a cutting-edge multiparametric flow cytometry assay designed to precisely monitor B-cell subsets implicated in autoimmune diseases. Discover how this high-throughput method enables the identification of pathogenic and regenerative B-cell populations, offering powerful..

Umer Raffat, one of the most respected investment analysts in the biotech and pharmaceutical industries will share key highlights on the latest advances and emerging trends in the field of oncology. Known for his deep expertise, Umer’s commentary is closely followed by investors, executives, and researchers across the life sciences sector. Don’t miss this rare..